| Primary |
| Immunosuppressant Drug Therapy |
26.8% |
| Immunosuppression |
12.5% |
| Renal Transplant |
12.5% |
| Prophylaxis Against Graft Versus Host Disease |
10.7% |
| Prophylaxis Against Transplant Rejection |
7.1% |
| Product Used For Unknown Indication |
5.4% |
| Pyoderma Gangrenosum |
5.4% |
| Goodpasture's Syndrome |
3.6% |
| Myocarditis |
3.6% |
| Pemphigoid |
3.6% |
| Stem Cell Transplant |
3.6% |
| Diffuse Large B-cell Lymphoma Stage Ii |
1.8% |
| Heart Transplant |
1.8% |
| Lupus Nephritis |
1.8% |
|
| Colitis |
16.0% |
| Off Label Use |
12.0% |
| Epstein-barr Viraemia |
4.0% |
| Gastrointestinal Erosion |
4.0% |
| Laryngeal Cancer |
4.0% |
| Lymphocytosis |
4.0% |
| Oesophageal Squamous Cell Carcinoma |
4.0% |
| Rash Papular |
4.0% |
| Renal Failure Acute |
4.0% |
| Renal Failure Chronic |
4.0% |
| Respiratory Failure |
4.0% |
| Streptococcus Test Positive |
4.0% |
| Therapeutic Response Unexpected With Drug Substitution |
4.0% |
| Thrombocytopenia |
4.0% |
| Thrombotic Microangiopathy |
4.0% |
| Tonsil Cancer |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Transaminases Increased |
4.0% |
| Transplant Failure |
4.0% |
| Treatment Failure |
4.0% |
|
| Secondary |
| Liver Transplant |
24.6% |
| Prophylaxis Against Transplant Rejection |
16.8% |
| Renal Transplant |
13.8% |
| Prophylaxis Against Renal Transplant Rejection |
9.0% |
| Immunosuppressant Drug Therapy |
8.4% |
| Immunosuppression |
7.2% |
| Product Used For Unknown Indication |
6.0% |
| Hepatitis C |
3.6% |
| Heart Transplant |
3.0% |
| Cardiac Failure |
1.2% |
| Cytomegalovirus Infection |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Glomerulonephritis Chronic |
1.2% |
| Acute Graft Rejection |
0.6% |
| Dermatomyositis |
0.6% |
| Herpes Simplex Hepatitis |
0.6% |
| Hyperlipidaemia |
0.6% |
| Triglyceride Increased |
0.6% |
|
| Ischaemic Stroke |
10.7% |
| Neutrophil Count Decreased |
7.1% |
| Renal Failure Acute |
7.1% |
| Transplant Rejection |
7.1% |
| Venous Stenosis |
7.1% |
| Walking Aid User |
7.1% |
| Weight Increased |
7.1% |
| Aspergillosis |
3.6% |
| Breast Cancer |
3.6% |
| Chest Pain |
3.6% |
| Diarrhoea |
3.6% |
| Dysarthria |
3.6% |
| Encephalitis |
3.6% |
| Febrile Neutropenia |
3.6% |
| Hyperkalaemia |
3.6% |
| Intestinal Obstruction |
3.6% |
| Lymphoproliferative Disorder |
3.6% |
| Meningitis Cryptococcal |
3.6% |
| Meningitis Pneumococcal |
3.6% |
| Nervous System Disorder |
3.6% |
|
| Concomitant |
| Prophylaxis Against Transplant Rejection |
51.7% |
| Renal Transplant |
10.3% |
| Immunosuppression |
5.7% |
| Cytomegalovirus Infection |
4.6% |
| Pulmonary Tuberculosis |
4.6% |
| Product Used For Unknown Indication |
3.4% |
| Systemic Lupus Erythematosus |
3.4% |
| Cord Blood Transplant Therapy |
2.3% |
| Essential Tremor |
2.3% |
| Liver Transplant |
2.3% |
| Secondary Immunodeficiency |
2.3% |
| Bone Marrow Conditioning Regimen |
1.1% |
| Guillain-barre Syndrome |
1.1% |
| Myasthenia Gravis Crisis |
1.1% |
| Pancreas Transplant Rejection |
1.1% |
| Pharyngitis |
1.1% |
| Stem Cell Transplant |
1.1% |
|
| Kidney Transplant Rejection |
15.9% |
| Immunosuppressant Drug Level Decreased |
11.4% |
| Vomiting |
11.4% |
| Off Label Use |
6.8% |
| Post Herpetic Neuralgia |
6.8% |
| Haemodialysis |
4.5% |
| Immunosuppressant Drug Level Increased |
4.5% |
| Pericardial Effusion |
4.5% |
| Thrombotic Microangiopathy |
4.5% |
| Visual Impairment |
4.5% |
| Wound Complication |
4.5% |
| Complications Of Transplanted Kidney |
2.3% |
| Death |
2.3% |
| Electrocardiogram Qt Prolonged |
2.3% |
| Epstein-barr Viraemia |
2.3% |
| Heart Transplant Rejection |
2.3% |
| Hyperprolactinaemia |
2.3% |
| Interstitial Lung Disease |
2.3% |
| Intestinal Perforation |
2.3% |
| Liver Transplant Rejection |
2.3% |
|
